CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 37.53

CSPC Innovation Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.3% to reach an intraday low of CNY 37.53. This performance comes amid a challenging backdrop for the company, which has reported negative results for the last ten consecutive quarters. In terms of financial metrics, CSPC's return on capital employed (ROCE) stands at a low -9.81%, and its inventory turnover ratio is at 3.51 times, indicating operational inefficiencies. The company's net profit for the latest quarter was CNY -95.43 million, reflecting a significant decline of 47.33%. Over the past year, CSPC has underperformed the broader market, with a return of -29.14% compared to the China Shanghai Composite's gain of 7.03%. Despite a strong performance over the longer term, with a 184.6% increase over three years, recent trends suggest a challenging environment for the company. CSPC's market capitalization is CNY 33,148 million, and it currently offers a dividend yield of 0%.